Trial Profile
Trastuzumab emtansine in patients with metastatic HER2-positive breast cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Sep 2008
Price :
$35
*
At a glance
- Drugs Trastuzumab emtansine (Primary)
- Indications Advanced breast cancer; HER2 positive breast cancer
- Focus Therapeutic Use
- 16 Sep 2008 New trial record.
- 06 Sep 2008 Interim findings presented at the American Society of Clinical Oncology's Breast Cancer Symposium in September.